bpc 157 supplement discounts BPC-157 – Mark Hyman, MD BPC-157 & The Gut-Brain Axis:

The top dose produced 20.9% average weight loss over 72 weeks and 20.2% in a direct comparison with semaglutides 13.7%. Its second receptor, GIP, separates tirzepatide from approved single-receptor GLP-1 drugs and helps explain the larger population-level weight loss. That 20.9% came from participants averaging about 105 kg at a BMI of 38, most of whom were sedentary

The primary concerns with nasal peptides involve nasal irritation if formulations arent pH-optimized, potential mucosal damage from preservatives, and variable absorption due to nasal congestion

STEP 2 confirmed efficacy in diabetic populations (9.6% weight reduction)

Lyophilized powder maintains stability for 2-3 years at freezer temperatures (-20C to -80C) or 1-2 years refrigerated at 2-8C